ClinicalTrials.gov
ClinicalTrials.gov Menu

Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma (MEL53)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01264731
Recruitment Status : Completed
First Posted : December 22, 2010
Last Update Posted : December 16, 2016
Sponsor:
Information provided by (Responsible Party):
Craig L Slingluff, Jr, University of Virginia

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2012
  Actual Study Completion Date : June 2012